Your browser doesn't support javascript.
loading
Characterization of Prototype Gummy Formulations Provides Insight into Setting Quality Standards.
Adeleke, Oluwatoyin A; Abedin, Saba.
Affiliation
  • Adeleke OA; Preclinical Laboratory for Drug Delivery Innovations, College of Pharmacy, Faculty of Health, Dalhousie University, Halifax, Nova Scotia, B3H 4R2, Canada. oadeleke@dal.ca.
  • Abedin S; School of Biomedical Engineering, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, B3H 3J5, Canada. oadeleke@dal.ca.
AAPS PharmSciTech ; 25(6): 155, 2024 Jul 03.
Article in En | MEDLINE | ID: mdl-38960983
ABSTRACT
Gummy formulations are considered suitable alternatives to traditional oral dosage forms like tablets and capsules due to their merits that include chewability, softness/flexibility, improved drug release, administration without water, appealing organoleptic properties, better patient compliance, easy preparation and usefulness for persons of different ages (e.g. children). Though there is increasing interest in gummy formulations containing drugs, measurable parameters, and specification limits for evaluating their quality are scarce. Quality check forms an essential part of the pharmaceutical development process because drug products must be distributed as consistently stable, safe, and therapeutically effective entities. Consequently, some quality parameters that could contribute to the overall performance of typical gummy formulations were investigated employing six brands of non-medicinal gummies as specimens. Accordingly, key physicochemical and micromechanical characteristics namely adhesiveness (0.009 - 0.028 mJ), adhesive force (0.009 - 0.055 N), chewiness (2.780 - 6.753 N), cohesiveness (0.910 - 0.990), hardness (2.984 - 7.453 N), springiness (0.960 - 1.000), and resilience (0.388 - 0.572), matrix firmness - compression load (2.653 - 6.753 N) and work done (3.288 - 6.829 mJ), rupture (5.315 - 29.016 N), moisture content (< 5%), weight uniformity (< 2.5 g; < 7.5% deviation), and intraoral dissolution pH (≥ 3.5 ≤ 6.8) were quantified to identify measures that may potentially function as specification limits and serve as prospective reference points for evaluating the quality of gummy formulations. Findings from this work contribute to ongoing efforts to standardize the quality control strategies for gummy formulations, particularly those intended for oral drug delivery.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Compounding Language: En Journal: AAPS PharmSciTech Journal subject: FARMACOLOGIA Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Compounding Language: En Journal: AAPS PharmSciTech Journal subject: FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: